Litcius/Paper detail

Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascade

Anuradha Kirtonia, Gouri Pandya, Aishwarya Singh, Rachana Kumari, Bhavana Singh, Sonia Kapoor, Ekta Khattar, Amit Kumar Pandey, Manoj Garg

2025Life Sciences14 citationsDOI

Topics & Concepts

KRASProtein kinase BPancreatic ductal adenocarcinomaMAPK/ERK pathwayCancer researchPI3K/AKT/mTOR pathwayDNA damageSignal transductionPancreatic cancerMedicineBiologyInternal medicineDNACancerCell biologyGeneticsColorectal cancerMicroRNA in disease regulationRNA modifications and cancerEpigenetics and DNA Methylation
Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascade | Litcius